Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.
about
Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteersUp-dosing with bilastine results in improved effectiveness in cold contact urticariaTreatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastineRole of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statementBilastine: in allergic rhinitis and urticaria.Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticariaEvaluation of the single-dose pharmacokinetics of bilastine in subjects with various degrees of renal insufficiency.On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.The role and choice criteria of antihistamines in allergy management - expert opinion.Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.Bilastine for the treatment of urticaria.Effects of central nervous system drugs on driving: speed variability versus standard deviation of lateral position as outcome measure of the on-the-road driving test.Bilastine: new insight into antihistamine treatment.Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study.The role of P-glycoprotein in CNS antihistamine effects.
P2860
Q24563637-A07DD6FF-2A0B-45AB-B601-651018496D7DQ24629114-CDF3FFEE-8018-4052-9BCE-26B42197F73DQ26750723-20F66F6F-383D-4767-90FD-25ADC110CE15Q26769045-13757154-9663-4223-A9A3-B3E5F23F6C1BQ34639105-191BA780-F22C-4642-BB7C-49D50DC2EF09Q36833151-8E165AA4-5B84-477C-8B79-78D833C7623FQ37115078-A4222442-28CC-42DB-89EC-DA9539894C41Q37184429-9976BF8C-6C59-417B-9C75-DC7ACB0D4F07Q37531868-EE6EB84B-0BF9-4AA3-936C-F202DB764FA4Q37633928-2329C618-0A6C-4D71-AF64-6DE6DB113DBCQ38107004-729BC0E2-01E3-4183-941B-6EC9203DA901Q38174544-EED6B19D-8497-46A1-B017-AE99BADCBB66Q38423124-3BBFE936-BA02-43C7-A679-244EA0AD4021Q38634137-4953FBCC-9C3F-48E8-8B2A-841AF59F2CD7Q39280604-08C4B234-FA65-4A29-B071-6A454153EC34Q42052228-8DB0F553-9EB1-4AA4-8DD9-C55B7D684937Q47933632-32367B85-41A4-4627-A3FA-8BA58811B1B3Q48091466-75B780C1-E915-4A8C-9603-81E2A9B02C1AQ48093193-D87690E1-2F9B-4564-8AE8-F37A5642E9E1
P2860
Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Acute and subchronic effects o ...... ormance in healthy volunteers.
@ast
Acute and subchronic effects o ...... ormance in healthy volunteers.
@en
Acute and subchronic effects of bilastine
@nl
type
label
Acute and subchronic effects o ...... ormance in healthy volunteers.
@ast
Acute and subchronic effects o ...... ormance in healthy volunteers.
@en
Acute and subchronic effects of bilastine
@nl
prefLabel
Acute and subchronic effects o ...... ormance in healthy volunteers.
@ast
Acute and subchronic effects o ...... ormance in healthy volunteers.
@en
Acute and subchronic effects of bilastine
@nl
P2093
P2860
P356
P1476
Acute and subchronic effects o ...... ormance in healthy volunteers.
@en
P2093
Anita C M Van Oers
Eef L Theunissen
Johannes G Ramaekers
Román Valiente
P2860
P304
P356
10.1177/0269881110382467
P407
P50
P577
2010-09-20T00:00:00Z